Aura Biosciences

Aura Biosciences

Biotechnology, 85 Bolton St, Boston, Massachusetts, 02140, United States, 51-200 Employees

aurabiosciences.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 61********

Who is AURA BIOSCIENCES

Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates (VDC), a novel class of therapies, for the treatment of multiple oncology indications. At ...

Read More

map
  • 85 Bolton St, Boston, Massachusetts, 02140, United States Headquarters: 85 Bolton St, Boston, Massachusetts, 02140, United States
  • 2009 Date Founded: 2009
  • 51-200 Employees: 51-200
  • dollar-icon Revenue: $10 Million to $25 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

checked-icon Does something look wrong? Fix it. | View contact records from AURA BIOSCIENCES

Aura Biosciences Org Chart and Mapping

Employees

James Othus

Senior Quality Engineer

Keith Faucher

VP of Device Development and Innovation

Ryan Clarke

Sr. Manager Quality Systems and Compliance

Jordan Jacobson

Sr. Manager, Talent Acquisition

Sean Riley

Human Resources Manager

Balcar Singh

Head of Supply Chain & External Manufacturing

Hemangi Yagnik

Associate Director, Regulatory Operations

Fungayi Rowlette

Sr. Associate (Lead) Documentation and Training

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Aura Biosciences

Answer: Aura Biosciences's headquarters are located at 85 Bolton St, Boston, Massachusetts, 02140, United States

Answer: Aura Biosciences's phone number is 61********

Answer: Aura Biosciences's official website is https://aurabiosciences.com

Answer: Aura Biosciences's revenue is $10 Million to $25 Million

Answer: Aura Biosciences has 51-200 employees

Answer: Aura Biosciences is in Biotechnology

Answer: Aura Biosciences contact info: Phone number: 61******** Website: https://aurabiosciences.com

Answer: Aura Biosciences is a clinical-stage biotechnology company developing virus-like drug conjugates (VDC), a novel class of therapies, for the treatment of multiple oncology indications. At Aura, our mission is to deliver meaningful therapeutic benefit to a range of cancer indications with high unmet need in which we believe we can establish a new standard of care. We are driven by our passion and commitment to science and the patients battling cancer who are relying on us to pioneer these new therapies. We are focusing the initial development of our VDC technology platform to treat tumors of high unmet need in ocular and urologic oncology. Belzupacap sarotalocan (bel-sar), our first VDC candidate, is being developed for the first-line treatment of early-stage choroidal melanoma, a rare disease with no drugs approved. Beyond early-stage choroidal melanoma, we are developing bel-sar in additional ocular oncology indications, including choroidal metastasis. Leveraging our VDCs broad tumor targeting capabilities, we have also initiated a clinical program in non-muscle invasive bladder cancer, or NMIBC, our first non-ocular solid tumor indication.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access